Daniel A. Macuga Sells 3,791 Shares of USANA Health Sciences, Inc. (NYSE:USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) insider Daniel A. Macuga sold 3,791 shares of USANA Health Sciences stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $47.14, for a total transaction of $178,707.74. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

USANA Health Sciences Price Performance

Shares of USNA stock opened at $45.55 on Friday. USANA Health Sciences, Inc. has a 12 month low of $41.45 and a 12 month high of $69.60. The firm has a market capitalization of $876.38 million, a P/E ratio of 14.19, a P/E/G ratio of 1.43 and a beta of 0.94. The company’s fifty day moving average price is $46.62 and its two-hundred day moving average price is $48.36.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.35. USANA Health Sciences had a net margin of 6.88% and a return on equity of 12.80%. The firm had revenue of $221.08 million for the quarter, compared to analyst estimates of $206.70 million. On average, sell-side analysts anticipate that USANA Health Sciences, Inc. will post 2.75 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Friday, January 12th. DA Davidson decreased their price target on shares of USANA Health Sciences from $53.00 to $48.00 and set a “neutral” rating for the company in a research report on Thursday, February 22nd.

Hedge Funds Weigh In On USANA Health Sciences

A number of institutional investors have recently added to or reduced their stakes in USNA. Quest Partners LLC acquired a new stake in shares of USANA Health Sciences in the 4th quarter valued at about $66,000. CWM LLC lifted its position in shares of USANA Health Sciences by 49.6% in the 4th quarter. CWM LLC now owns 1,267 shares of the company’s stock valued at $68,000 after acquiring an additional 420 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of USANA Health Sciences by 60.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,376 shares of the company’s stock valued at $198,000 after acquiring an additional 1,274 shares in the last quarter. Trexquant Investment LP purchased a new stake in shares of USANA Health Sciences in the 4th quarter valued at approximately $266,000. Finally, Teacher Retirement System of Texas purchased a new stake in shares of USANA Health Sciences in the 3rd quarter valued at approximately $297,000. Institutional investors and hedge funds own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.